KLRK1 and neoplasm: Once T cells have infiltrated a tumour, MHC-I, ICAM-1, RAE-1γ and NKG2D promote T cell arrest, tumour cell engagement and were found to be essential for the efficacy of a combination of radiotherapy and CTLA-4 blockade in mice [37].